- Home
- ASRT vs MYO Comparison
ASRT vs MYO Comparison
Compare ASRT & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- MYO
- Stock Information
- Founded
- ASRT 1995
- MYO 2004
- Country
- ASRT United States
- MYO United States
- Employees
- ASRT N/A
- MYO 106
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- MYO Industrial Specialties
- Sector
- ASRT Health Care
- MYO Health Care
- Exchange
- ASRT Nasdaq
- MYO Nasdaq
- Market Cap
- ASRT 123.9M
- MYO 121.5M
- IPO Year
- ASRT 1997
- MYO 2017
- Fundamental
- Price
- ASRT $1.12
- MYO $4.02
- Analyst Decision
- ASRT Strong Buy
- MYO Strong Buy
- Analyst Count
- ASRT 5
- MYO 4
- Target Price
- ASRT $3.35
- MYO $7.63
- AVG Volume (30 Days)
- ASRT 437.0K
- MYO 131.5K
- Earning Date
- ASRT 11-06-2024
- MYO 11-05-2024
- Dividend Yield
- ASRT N/A
- MYO N/A
- EPS Growth
- ASRT N/A
- MYO N/A
- EPS
- ASRT N/A
- MYO N/A
- Revenue
- ASRT $132,186,000.00
- MYO $21,111,062.00
- Revenue This Year
- ASRT N/A
- MYO $53.19
- Revenue Next Year
- ASRT $4.68
- MYO $39.01
- P/E Ratio
- ASRT N/A
- MYO N/A
- Revenue Growth
- ASRT N/A
- MYO 21.22
- 52 Week Low
- ASRT $0.73
- MYO $0.99
- 52 Week High
- ASRT $2.60
- MYO $5.64
- Technical
- Relative Strength Index (RSI)
- ASRT 41.29
- MYO 53.13
- Support Level
- ASRT $1.15
- MYO $3.77
- Resistance Level
- ASRT $1.25
- MYO $4.06
- Average True Range (ATR)
- ASRT 0.06
- MYO 0.20
- MACD
- ASRT -0.01
- MYO 0.02
- Stochastic Oscillator
- ASRT 10.71
- MYO 78.05
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).